1. 243P Skin biopsies for pharmacodynamic studies of tebentafusp: A novel bispecific molecule against the melanocytic antigen gp100. (December 2022) Authors: Stäger, R.; Tastanova, A.; Ramelyte, E.; Levesque, M.P.; Dummer, R.; Meier-Schiesser, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ROS induction as a strategy to target persister cancer cell metabolism. (October 2022) Authors: Eichhoff, O.; Stoffel, C.; Briker, L.; Turko, P.; Karsai, G.; Paulitschke, V.; Zamboni, N.; Balazs, Z.; Tastanova, A.; Wegmann, R.; Mena, J.; Viswanathan, V.; TuPro, C.; Krauthammer, M.; Schreiber, S.; Hornemann, T.; Distel, M.; Snijder, B.; Dummer, R.; Levesque, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗